IBSA USA, the U.S. subsidiary of the Swiss pharmaceutical company IBSA, announced today that the Food and Drug Administration (FDA) has approved VYBRIQUEtm, the first sildenafil oral film available to ...
Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditionsTORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ...
Aspivix - a FemTech company dedicated to modernizing gynecological care - announced the results of a multicenter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results